The Food and Drug Administration (FDA) advisory group who evaluate the efficacy and safety of vaccines have rejected the request for Pfizer booster shots. However, the White House – desperately trying to push as many needle jabs as possible – was already on track to begin giving booster shots this month. The implication here is that the White House was not following the recommendations of the FDA or the science.
WASHINGTON DC – A U.S. Food and Drug Administration (FDA) advisory panel voted Friday against approval of Pfizer (PFE)/BioNTech’s (BNTX) third dose for the U.S.
The vote comes after a heated debate in recent weeks over the need for booster or additional shots, which both mRNA companies — Pfizer and Moderna (MRNA) — have advocated for.
Dr. Peter Marks, the FDA’s leading expert on vaccines, touched on the controversy in his introductory remarks. “We know that there may be differing opinions of the interpretation of the data regarding the potential need for additional doses, and we strongly encourage all the different viewpoints to be voiced and discussed regarding the data, which is complex, and evolving,” Marks said.



Politico outlines the request letter [